81
Participants
Start Date
September 30, 2014
Primary Completion Date
September 30, 2017
Study Completion Date
September 30, 2017
Rivaroxaban
University of Alberta Hospital, Edmonton
Queen Elizabeth II Hospital, Halifax
Hamilton General Hospital, Hamilton
St. Joseph's Healthcare Hamilton, Hamilton
The Ottawa Hospital, Ottawa
Jewish General Hospital, Montreal
Collaborators (1)
Heart and Stroke Foundation of Canada
OTHER
Bayer
INDUSTRY
Hamilton Health Sciences Corporation
OTHER
Jewish General Hospital
OTHER
University of Alberta
OTHER
The Ottawa Hospital
OTHER
Queen Elizabeth II Health Sciences Centre
OTHER
St. Joseph's Healthcare Hamilton
OTHER